Publications by authors named "Cy Wilkins"

Claim this Profile
M
Medical Management of Acute Venous Thromboembolism.
Cy R Wilkins, Andrew M Chiu, Sirish A Kishore

Semin Intervent Radiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Realizing the scope of venous and arterial thrombosis in cyclin-dependent kinase 4/6 inhibitors in hormone positive breast cancer.
Cy R Wilkins, Jeffrey I Zwicker

Eur J Intern Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of romiplostim for antineoplastic therapy-induced thrombocytopenia in gynecologic and breast cancers.
Sara Moufarrij, Roisin E O'Cearbhaill, Qin Zhou, Alexia Iasonos, Simon Mantha, Cy R Wilkins

Gynecol Oncol Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
Shuchi Gulati, Chih-Yuan Hsu, Surbhi Shah, Pankil K Shah, Rebecca Zon, Cy R Wilkins

JAMA Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endovascular Management of Venous Thromboembolic Disease in the Oncologic Patient Population.
Sirish A Kishore, Raazi Bajwa, Layla Van Doren, Cy Wilkins, Gerard J O'Sullivan

Curr Oncol Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Romiplostim for chemotherapy-induced thrombocytopenia: Efficacy and safety of extended use.
Cy R Wilkins, Jocelyn Ortiz, Leah J Gilbert, Shen Yin, Jodi V Mones

Res Pract Thromb Haemost· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis.
Katrina Piedra, Tim Peterson, Carlyn Tan, Jennifer Orozco, Malin Hultcrantz, Cy R Wilkins

Br J Haematol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia.
Gerald A Soff, Yimei Miao, Gemma Bendheim, Jeanette Batista, Jodi V Mones, Cy R Wilkins

J Clin Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban treatment of cancer-associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience.
Gerald A Soff, Jodi Mones, Cy Wilkins, Sean Devlin, Eva Haegler-Laube

Res Pract Thromb Haemost· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Paradigm Between Leukocytosis, G-CSF Secretion, Neutrophil-to-Lymphocyte Ratio, Myeloid-Derived Suppressor Cells, and Prognosis in Non-small Cell Lung Cancer.
Montreh Tavakkoli, Cy R Wilkins, Jodi V Mones, Michael J Mauro

Front Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable complete remission from castration-resistant prostate cancer with sipuleucel-T after estrogen withdrawal.
Tanya B Dorff, Cy Wilkins, Mehmet Hepgur, David I Quinn

Clin Genitourin Cancer· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis